BSE filing, BSE: 524238. Summary written from the filing by ALFA Finder's alert engine.
Gujarat Inject (Kerala) Ltd: key numbers
- Share price
- ₹11.18
- Market cap
- ₹163.8 Cr
- Revenue (annual)
- ₹36.32 Cr
- Net profit (annual)
- ₹1.81 Cr
- P/E (TTM)
- 54.7×Sector 46.1×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gujarat Inject (Kerala) Ltd
All →Gujarat Inject (Kerala) Board Meeting Date
Gujarat Inject Kerala Ltd scheduled a board meeting on 26 October 2026 to consider preferential allotment of shares and warrants. No amount was specified in the intimation.
Gujarat Inject (Kerala) Other Announcement
Gujarat Inject Kerala Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. The filing provides details of shareholder categories.
Gujarat Inject (Kerala) Bags ₹6.25 Cr Order from Deon Energy Limited
Gujarat Inject Kerala received a Rs.6.25 Crore purchase order from Deon Energy for 8,065 solar panels (620 Wp). Delivery is due by October 2026.
- Value
- ₹6.25 Cr
- From
- Deon Energy Limited
- Execution
- October 2026
Gujarat Inject (Kerala) Bags ₹4.86 Cr Order from Zentaraa Infra Projects Private Limited
Gujarat Inject Kerala Ltd received a purchase order for 3,600 solar PV modules from Zentaraa Infra Projects Private Limited, valued at approximately ₹4.86 Crore.
- Value
- ₹4.86 Cr
- From
- Zentaraa Infra Projects Private Limited
- Execution
- October 2026
- Solar PV Modules
- 3600.0 units
Gujarat Inject (Kerala) Annual General Meeting
Gujarat Inject Kerala Ltd held its 35th AGM on September 29, 2026, to conduct routine business, including the adoption of financial statements and director appointments.
Gujarat Inject (Kerala) Stock Split
Gujarat Inject Kerala Ltd announced the completion of its 1:10 stock split. Shareholders holding physical certificates must now submit documentation to the RTA to receive dematerialized shares.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.